SCHEMBL8883969

SCHEMBL8883969

O=P(O)(O)C1CCc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 1/20 0.61
IDO1 P14902 2/20 0.43
PDPK1 O15530 1/20 0.43
PIN1 Q13526 2/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CYP11B2 P19099 1/20 0.41
HTT P42858 1/20 0.41
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
TAS1R2 Q8TE23 2/20 0.39
SRD5A1 P18405 1/20 0.38
SLC18A3 Q16572 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15406171 0.89 ACP3 (0.58) ACP3IDO1PDPK1HTTTAS1R3
SCHEMBL8093012 0.77 SMN1; SMN2 (0.49) ACP3
SCHEMBL28165745 0.73 IDO1 (0.56) ACP3IDO1PDPK1PIN1CA1
SCHEMBL28883743 0.73 IDO1 (0.56) ACP3IDO1PDPK1PIN1CA1
SCHEMBL10706985 0.69 ACP3 (0.40) ACP3CA2HTT
SCHEMBL30734419 0.69 ACP3 (0.56) ACP3
SCHEMBL3248046 0.69 ACP3 (0.56) ACP3
SCHEMBL57132 0.69 IDO1 (0.50) ACP3IDO1PDPK1PIN1CYP11B2
SCHEMBL3418678 0.69 IDO1 (0.50) ACP3IDO1PDPK1PIN1CYP11B2
SCHEMBL21114381 0.69 IDO1 (0.50) ACP3IDO1PDPK1PIN1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5686621-A Substituted hydrindanes for the treatment of angiogenesis-dependent diseases ALCON LABORATORIES, INC. (US) 1997-11-11 US disclosed
US-5464866-A Substituted hydrindanes for the treatment of angiogenesis-dependent diseases ALCON LABORATORIES, INC. (US) 1995-11-07 US disclosed
WO-1994004143-A1 SUBSTITUTED HYDRINDANES FOR THE TREATMENT OF ANGIOGENESIS-DEPENDENT DISEASES ALCON LABORATORIES, INC. (US) 1994-03-03 WO disclosed